[1] De Sousa SMD, Norman RJP. Metabolic syndrome, diet and exercise [J]. Best Pract Res Clin Obstet Gynaecol, 2016, 37: 140-151. [2] Berger J, Moller DE. The mechanisms of action of PPARs [J]. Annu Rev Med, 2002, 53: 409-435. [3] Kuwahara K, Honda T, Nakagawa T, et al. Leisure-time exercise, physical activity during work and commuting, and risk of metabolic syndrome [J]. Endocrine, 2016, 53(3): 710-721. [4] Federation ID. The IDF consensus worldwide definition of the metabolic syndrome [J]. Ožirenie i Metabolizm, 2005, 2(3): 47-49. [5] 颜虹,徐勇勇. 医学统计学[M]. 3版. 北京:人民卫生出版社, 2015: 242. [6] Bedford TG, Tipton CM, Wilson NC, et al. Maximum oxygen consumption of rats and its changes with various experimental procedures [J]. J Appl Physiol Respir Environ Exerc Physiol, 1979, 47(6):1278-1283. [7] Gilde AJ, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors at the crossroads of obesity, diabetes, and cardiovascular disease [J]. J Am Coll Cardiol, 2006, 48(Suppl): A25-A32. [8] Kersten S. Integrated physiology and systems biology of PPARα [J]. Mol Metab, 2014, 3(4): 354-371. [9] Yan Y, Wang ZB, Tang CK. PPARs mediate the regulation of energy metabolism by long- chain fatty acids [J]. Sheng Li Ke Xue Jin Zhan, 2016, 47(1): 1-6. [10] Ibarra-Lara L, Sanchez-Aguilar M, Sanchez-Mendoza A, et al. Fenofibrate therapy restores antioxidant protection and improves myocardial insulin resistance in a rat model of metabolic syndrome and myocardial ischemia: the role of angiotensin II [J]. Molecules, 2016, 22(1): 31-48. [11] Tsunoda F, Asztalos IB, Horvath KV, et al. Fenofibrate, HDL, and cardiovascular disease in type-2 diabetes: The DAIS trial [J]. Atherosclerosis, 2016, 247: 35-39. [12] Song D, Chu Z, Min L, et al. Gemfibrozil not fenofibrate decreases systemic glucose level via PPARalpha [J]. Pharmazie, 2016, 71(4): 205-212. [13] Lucero D, Miksztowicz V, Macri V, et al. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-alpha [J]. Clin Investig Arterioscler, 2015, 27 (4): 167-174. [14] Lee TW, Bai KJ, Lee TI, et al. PPARs modulate cardiac metabolism and mitochondrial function in diabetes [J]. J Biomed Sci, 2017, 24(1): 5. [15] 胡莲美,郑文岭,朴英杰. 过氧化物酶体增殖物激活受体的医学重要性[J]. 医学分子生物杂志, 2005, 2(2):140-142. [16] Akiyama TE, Meinke PT, Berger JP. PPAR ligands: potential therapies for metabolic syndrome [J]. Curr Diab Rep Feb, 2005, 5(1): 45-52. [17] Chen L, Jia Z, Yang G. PPARs and Metabolic Syndrome [J]. PPAR Res, 2014, 2014: 832606. [18] Gross B, Pawlak M, Lefebvre P, et al. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD [J]. Nat Rev Endocrinol, 2017, 13(1): 36-49. [19] Fuentes E, Guzman-Jofre L, Moore-Carrasco R, et al. Role of PPARs in inflammatory processes associated with metabolic syndrome (review) [J]. Mol Med Rep, 2013, 8(6): 1611-1616. [20] Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation [J]. Trends Endocrinol Metab, 2012, 23(7): 351-363. [21] Matsuo T, So R, Shimojo N, et al. Effect of aerobic exercise training followed by a low-calorie diet on metabolic syndrome risk factors in men [J]. Nutr Metab Cardiovasc Dis, 2015, 25(9): 832-838. [22] Batatinha HA, Lima EA, Teixeira AA, et al. Association between aerobic exercise and rosiglitazone avoided the NAFLD and liver inflammation exacerbated in PPAR-alpha knockout mice [J]. J Cell Physiol, 2017, 232(5): 1008-1019. [23] Zhang S, Liu Y, Li Q, et al. Exercise improved rat metabolism by raising PPAR-alpha [J]. Int J Sports Med, 2011, 32(8): 568-573. [24] Santos MH, Higuchi Mde L, Tucci PJ, et al. Previous exercise training increases levels of PPAR-alpha in long-term post-myocardial infarction in rats, which is correlated with better inflammatory response [J]. Clinics (Sao Paulo), 2016, 71(3): 163-168. [25] Campbell FM, Kozak R, Wagner A, et al. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase [J]. J Biol Chem, 2002, 277(6): 4098-4103. |